Ace-Inhibitors in Severe Hypertension

References

• Brunner H.R., Gavras H., Waeber B., Kershaw G.R., Turini G.A., Vukovich R.A., McKinstry D., and Gavras I. Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients. Ann. Intern. Med. 90: 19–23, 1979
   Google Scholar
• Aurell M., Delin K., and Herlitz H. Captopril in treatment resistant essential and renal hypertension. Scand. J. Urol. Nephrol. 16: 243–249, 1982
   Google Scholar
• Groel J.T., Tadros S.S., Dreslinski G.R., and Jenkins A.C. Long-term antihypertensive therapy with captopril. Hypertension vol 5 no 5: III: 145–151, 1983
   Google Scholar
• Havelka J., Boerlin H.J., Studor A., Greminger P., Tenschert W., Luescher T., Siegenthaler W., Vetter W., Walger P., and Vetter H. Long-term experience with captopril in severe hypertension. Br. J. Clin. Pharmac. 14 (suppl 2):71–76, 1982
   Google Scholar
• Hodsman G.P., Brown J.J., Cumming A.M.M., Davies D.L., East B.W., Lever A.F., Morton J.J., Murray G.D., Robertson J.I.S. Enalapril (MK 421) in the treatment of hypertension with renal artery stenosis. Journal of Hypertension 1 (suppl 1): 109–117, 1983
   Google Scholar
• Atkinson A.B., Brown J.J., Cumming A.M.M., Fraser R., Lever A.F., Leckie B.J., Morton J.J., Robertson J.I.S., Davies D.L. Captopril in the management of hypertension with renal artery stenosis: its long-term effect as a predictor of surgical outcome. Am. J. Cardiol. 49: 1460–1466, 1982
   Google Scholar
• Farrow P.R., Wilkinson R. Reversible renal failure during treatment with captopril. Br. Med. J. 1: 1680, 1979.
   Google Scholar
• Textor S.C., Gephardt G.N., Bravo E.L., Tarazi R.C., Fouad F.M., Tubbs R., McMahon J.T. Membraneous glomerulopathy associated with captopril therapy. Am. J. Med. 74: 705–710, 1983
   Google Scholar
• Collste P., Haglund K., Lundgren G., Magnusson G., Östman J. Reversible renal failure during treatment with captoril. Lancet II: 612–613, 1979
   Google Scholar
• Hricik D.E., Browning P.J., Kopelman R., Goorno W.E., Madias N.E., Dzau V. Captopril-induced functional renal insufficiency in patients with bilateral renal artery stenosis or renal artery stenosis in a solitary kidney. N. Engl. J. Med. 308: 373–376, 1983
   Google Scholar
• Levens R.L., Peach M.J., Carey R.M. Role of the intrarenal renin-angiotensin system in the control of renal function. Circ. Res. 48: 157–167, 1981
   Google Scholar
• Hollenberg N.K. Medical therapy of renovascular hypertension: efficacy and safety of captopril in 269 patients. Cardiovascular Reviews and Reports. In press.
   Google Scholar
• Watson M.L., Bell G.M., Muin A.L., Buist T.A.S., Kellet R.J., Padfield P.L. Captopril diuretic combination in severe renovascular disease: a cautionary note. Lancet II: 404–405, 1983
   Google Scholar
• Wenting G.J., Tan-Tjiong, Derkx F.H.M., DeBruyn J.H.B., Man In't Veld, A.J., Schalekamp M.A.D.H. Split-renal function after captopril in unilateral renal artery stenosis. Br. Med. J. 288: 886–890, 1984
   Google Scholar
• Huang W-C., Ploth D.W., Bell D., Work J., Navar L.G. Bilateral renal function responses to converting enzyme inhibitor (SQ 20881) in two-kidney, one clip Goldblatt hypertension rats. Hypertension 3: 285–293, 1981
   Google Scholar
• Hollenberg N.K. Converting enzyme inhibition: Implication for renal perfusion and function. Clin. Exp. Pharm. Physiol. 7 (suppl): 73–79, 1982
   Google Scholar
• Mogensen C.E. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br. Med. J. 285: 685–688, 1982
   Google Scholar
• Björck S., Nyberg G., Herlitz H., Granérus G., Mulec H., Aurell M. Captopril treatment of hypertension in diabetic nephropathy. Diabetic Nephropathy. In press, 1984.
   Google Scholar
• Ljungman S., Aurell M., Hartford M., Wikstrand J., Berg-lund G. Effect of subpressor doses of angiotensin II on renal hemodynamics in relation to blood pressure. Hypertension 5:368–374, 1983
   Google Scholar
• Delin K., Aurell M., Herlitz H. Captopril in the treatment of hypertension in predialytic end-stage renal disease. Contr. Nephrol, in press.
   Google Scholar
• Aurell M., Delin K., Herlitz H., Mulec H. Captopril treatment in hypertensive dialysis patients. Scand. J. Urol. Nephrol. 16: 251–256, 1982
   Google Scholar
• Wauters J.R., Waeber B., Brunner HR., Guignard J-P., Turini G.A., Gavras H. Uncontrollable hypertension in patients on hemodialysis: Long-term treatment with captopril and salt subtraction. Clin. Nephrol. 16: 86–92. 1981
   Google Scholar
• Whitman III H.H., Case D.B., Laragh J.H., Christian G.B., Mariea H., Leroy EC. Variable response to oral angio-tensin-converting-enzyme blockade in hypertensive scleroderma patients. Arthritis Rheum, 25: 241–248, 1982.
   Google Scholar
• Herlitz H., Edenö C., Mulec H., Westberg G., Aurell M. Captopril treatment of hypertension and renal failure in systemic lupus erythematosus. Nephron, in press.
   Google Scholar
• Zurier R.B., Damjanov I., Sayadoff M., Rothfield N.F. Prostaglandin E treatment of NZB/NZW F hybrid mice II. Prevention of glomerulonephritis. Arthritis Rheum. 20: 1449–1456, 1977
   Google Scholar
• Johnsén S-A. Prostaglandin associated immunosuppression focusing on human neonatal and maternal mononuclear leukocyte interactions. Academical thesis, Uniivrsity of Gothenburg, 1983.
   Google Scholar